抑癌基因p16与恶性肿瘤关系的研究进展
-
摘要: 肿瘤是一类细胞周期疾病,是多基因、长期共同作用的结果。在细胞周期中的任何一个相关基因、生长因子、细胞因子、激素等出现问题,都可能引起一系列反应,有的甚至是不可逆反应,随着时间的推移,慢慢地朝着恶性肿瘤方向发展。近几年有报道[1],抑癌基因p16的变异和恶性肿瘤关系非常密切。本文就抑癌基因p16与恶性肿瘤关系的研究进展作一综述。
-
[2] Travis J.Closing in on melanoma susceptibility gene(s)[J].Science,1992,258(5085):1080-1081. [2] Wettergren Y,Odin E,Nilsson S,et al.p16INK4a gene promoter hypermethylation in mucosa as a prognostic factor for patients with colorectal cancer[J].Mol Med,2008,14(7/8):412-421. [3] Kamb A,Gruis NA,Weaver-Feldhaus J,et al.A cell cycle regulator potentially involved in genesis of many tumor types[J].Science,1994,264(5157):436-440. [4] Serrano M,Hannon GJ,Beach D.A new regulatory motif in cell-cycle control causing specific inhibition of cyclinD/CDK4[J].Nature,1993,366(6456):704-707. [5] Barrick D.Biological regulation via ankyrin repeat folding[J].ACS Chem Biol,2009,4(1):19-22. [6] Morgan DO.Principles of CDK regulation[J].Nature,1995,374(6518):131-134. [7] Orlando DA,Lin CY,Bernard A,et al.Global control of cell-cycle transcription by coupled CDK and network oscillators[J].Nature,2008,453(7197):944-947. [8] 曾益新.肿瘤学[M].2版.北京:人民卫生出版社,2002:96-180. [9] 阮绪芝,梁玉华,杨宝胜.医学细胞生物学[M].北京:科学出版社,2002:179-198. [10] Hall M,Peters G.Genetic alterations of cyclins,cyclin-dependent kinases,and CDK inhibitors in human cancer[J].Adv Cancer Res,1996,68:67-108. [11] Wood PA,Yang X,Hrushesky WJ.Clock genes and cancer[J].Integr Cancer Ther,2009,8(4):303-308. [12] Li Y,Nichols MA,Shay JW,et al.Transcriptional repression of the D-type cyclin-dependent kinase inhibitor p16 by the retinoblastoma susceptibility gene product pRb[J].Cancer Res,1994,54(23):6078-6082. [13] Ginsberg D,Vairo G,Chittenden T,et al.E2F-4,a new member of the E2F transcription factor family,interacts with p107[J].Genes Dev,1994,8(22):2665-2679. [14] Cobrinik D,Vhyte P,Peeper DS,et al.Cell cycle-specific association of E2F with the p130 E1A-binding protein[J].Genes Dev,1993,7(12A):2392-2404. [15] Yan Z,DeGregori J,Shohet R,et al.Cdc6 is regulated by E2F and is essential for DNA replication in mammalian cells[J].Proc Natl Acad Sci USA,1998,95(7):3603-3608. [16] Bates S,Phillips AC,Clark PA,et al.p14ARF links the tumour suppressors RB and p53[J].Nature,1998,395(6698):124-125. [17] Pomerantz J,Schreiber-Agus N,Liegeois NJ,et al.The Ink4a tumor suppressor gene product,p19Arf,interacts with MDM2 and neutralizes MDM2s inhibition of p53[J].Cell,1998,92(6):713-723. [18] Kamijo T,Veber JD,Zambetti G,et al.Funtional and physical interactions of the ARF tumor suppressor with p53 and Mdm2[J].Proc Natl Acad Sci USA,1998,95(14):8292-8297. [19] Zhang Y,Xiong Y.Mutations in human ARF exon 2 disrupt its nucleolar localization and impair its ability to block nuclear export of MDM2 and p53[J].Mol Cell,1999,3(5):579-591. [20] Paya A,Alenda C,Perez-Carbonell L,et al.Utility of p16 immunohistochemistry for the identification of Lynch syndrome[J].Clin Cancer Res,2009,15(9):3156-3162. [21] 陈照立.p16抑癌基因研究进展及在口腔肿瘤中的作用[J].泸州医学院学报,2003,26(4):348-351. [22] Tanaka H,Shimada Y,Imamura M,et al.Multiple types of aberrations in the p16(INK4a) and p15(INK4b) genes in 30 esophageal squamous-cell-carcinoma cell lines[J].Int J Cancer,1997,70(4):437-442. [23] Shih YC,Kerr J,Liu J,et al.Rare mutations and no hypermethylation at the CDKN2A locus in epithelial ovarian tumours[J].Int J Cancer,1997,70(5):508-511. [24] Schutte M,Hruban RH,Geradts J,et al.Abrogation of the Rb/p16 tumor-suppressive pathway in virtually all pancreatic carcinomas[J].Cancer Res,1997,57(15):3126-3130. [25] Krimpenfort P,Ijpenberg A,Song JY,et al.p15 Ink4b is a critical tumour suppressor in the absence of p16Ink4a[J].Nature,2007,448(7156):943-946. [26] Mao L,Merlo A,Bedi G,et al.A novel p16INK4A transcript[J].Cancer Res,1995,55(14):2995-2997. [27] Herman JG,Graff JR,Myohanen S,et al.Methylation-specific PCR:a novel PCR assay for methylation Status of CpG Islands[J].Proc Natl Acad Sci USA,1996,93(18):9821-9826. [28] 周静,苏玉文.S-腺苷甲硫氨酸、DNA甲基化与肿瘤[J].现代肿瘤医学,2008,16(11):2019-2021. [29] Li E,Beard C,Jaenisch R.Role for DNA methylation in genomic imprinting[J].Nature,1993,366(6453):362-365. [30] Ogino S,Cantor M,Kawasaki T,et al.CpG island methylator phenotype(CIMP) of colorectal cancer is best characterised by quantitative DNA methylation analysis and prospective cohort studies[J].GUT,2006,55(7):1000-1006. [31] Bender CM,Pao MM,Jones PA.Inhibition of DNA methylation by 5-aza-2-deoxycytidine suppresses the growth of human tumor cell lines[J].Cancer Res,1998,58(1):95-101. [32] Tsygankov D,Liu Y,Sanoff HK,et al.A quantitative model for age-dependent expression of the p16INK4a tumor suppressor[J].Proc Natl Acad Sci USA,2009,106(39):16562-16567.
点击查看大图
计量
- 文章访问数: 3195
- HTML全文浏览量: 237
- PDF下载量: 122
- 被引次数: 0